These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6202005)

  • 1. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis.
    Dixon JS; Bird HA; Sitton NG; Pickup ME; Wright V
    Scand J Rheumatol; 1984; 13(1):39-44. PubMed ID: 6202005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Maddock J; Rees P; Holly F; Aylward M
    Curr Med Res Opin; 1975; 3(5):286-97. PubMed ID: 241598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis.
    Yildirim K; Karatay S; Melikoglu MA; Gureser G; Ugur M; Senel K
    Ann Clin Lab Sci; 2004; 34(4):423-6. PubMed ID: 15648784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of clinical assessments of disease activity in rheumatoid arthritis.
    Rhind VM; Bird HA; Wright V
    Ann Rheum Dis; 1980 Apr; 39(2):135-7. PubMed ID: 7387217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease activity in rheumatoid arthritis: fibrinogen is superior to the erythrocyte sedimentation rate.
    Arvidson NG; Larsson A; Larsen A
    Scand J Clin Lab Invest; 2002; 62(4):315-9. PubMed ID: 12476931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis.
    Aylward M; Maddock J; Wheeldon R; Parker RJ
    Rheumatol Rehabil; 1975 May; 14(2):101-14. PubMed ID: 238274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Paulus HE; Ramos B; Wong WK; Ahmed A; Bulpitt K; Park G; Sterz M; Clements P
    J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
    Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
    Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are inflammation parameters true signs of activity? A contribution to the problem of process activity and progression in chronic polyarthritis].
    Chlud K
    Z Rheumatol; 1985; 44(1):14-9. PubMed ID: 2580400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
    Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B
    Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
    Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
    Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Wolfe F
    J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of combination therapy and nonsteroidal antirheumatic agents on acute phase reactants in patients with rheumatoid arthritis].
    Berdnik-Gortan K; Bjelinski D
    Reumatizam; 1999; 46(1):12-6. PubMed ID: 11552614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.
    Inciarte-Mundo J; Victoria Hernández M; Ruiz-Esquide V; Raquel Cabrera-Villalba S; Ramirez J; Cuervo A; Pascal M; Yagüe J; Cañete JD; Sanmarti R
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):899-906. PubMed ID: 26841119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
    Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
    Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma viscosity--a new appraisal of its use as an index of disease activity in rheumatoid arthritis.
    Pickup ME; Dixon JS; Hallett C; Bird HA; Wright V
    Ann Rheum Dis; 1981 Jun; 40(3):272-5. PubMed ID: 7247471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the complex of immunoglobulin A and alpha-1-antitrypsin, its constituent components and the acute-phase response as measured by C-reactive protein in rheumatoid arthritis treated with gold or D-penicillamine.
    Dawes PT; Jackson R; Shadforth MF; Lewin IV; Stanworth DR
    Br J Rheumatol; 1987 Oct; 26(5):351-3. PubMed ID: 2444302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alpha 1 antichymotrypsin concentration as a marker of disease activity in rheumatoid arthritis.
    Chard MD; Calvin J; Price CP; Cawston TE; Hazleman BL
    Ann Rheum Dis; 1988 Aug; 47(8):665-71. PubMed ID: 3261967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.
    Dixon JS; Pickup ME; Lowe JR; Hallett C; Lee MR; Wright V
    Ann Rheum Dis; 1980 Aug; 39(4):301-11. PubMed ID: 7436556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.